SKP 818

Drug Profile

SKP 818

Alternative Names: KR 30818

Latest Information Update: 26 Mar 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Korea Research Institute of Chemical Technology
  • Developer SK Pharma
  • Class Benzopyrans; Pyrrolidinones; Small molecules
  • Mechanism of Action Potassium channel agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Myocardial ischaemia

Most Recent Events

  • 04 Jun 1998 Investigation in Myocardial ischaemia in South Korea (Unknown route)
  • 07 Apr 1998 A preclinical study has been added to the pharmacokinetics and the Ischaemic Heart Disease pharmacodynamics sections
  • 20 Nov 1996 Preclinical development for Myocardial ischaemia in South Korea (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top